Mnemosyne Pharmaceuticals Inc

Amendment
CIK: 0001542171·Biotechnology·DELAWARE·Filed: Feb 4, 2015
Total Offering

$12,952,680

Amount Sold

$12,332,334

Investors

6

First Sale

Feb 1, 2012

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2010
Non-Accredited Investors
No

Related Persons

NameRole
Vanessa King
Related Person
Frank Menniti
Related Person
Richard Horan
Related Person
James Bristol
Related Person
Peter Barrett
Related Person
William Koster
Related Person

Company

Mnemosyne Pharmaceuticals Inc

THREE DAVOL SQUARE

PROVIDENCE, RI, 02903

401-632-0383

SEC Filing

0000908662-15-000037

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Mnemosyne Pharmaceuticals Inc Form D Filing — $12,952,680 | FilingFlow